Zai Lab
ZLAB
25.31
-0.27
-1.06%
Zai Lab
US · ZLAB
#2554 by market cap
Listed 2017
25.31
-0.27
-1.06%
Live - 5344 symbols - heartbeat 13s ago
· 2026-10-08 04:01
Pre-market
25.05
-1.03%
After-hours
24.80
-2.02%
Overnight
24.55
-3.00%
- Market cap
- 2.84B
- P/E (TTM)i
- -14.89
- P/Bi
- 4.68
- EPSi
- -1.60
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on ZLAB?
Anonymous reader poll. Unscientific, not investment advice.
About Zai Lab
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
- Founded
- 2014
- CEO
- Dr. Samantha Du, PhD
- Employees
- 1,784
- Headquarters
- Shanghai, Shanghai, China
- Fiscal year end
- 12-31
- Website
- zailaboratory.com
Company profile
- Exchange
- US
- Symbol
- ZLAB
- Market-cap rank
- #2554
- Listing date
- 2017-09-20
- Market cap
- 2.84B
- Float cap
- 2.46B
- Shares out
- 112.27M
- Float shares
- 97.11M
Sectors & themes
Quote time 2026-10-08 04:01:59 · For reference only, not investment advice and not tailored to your situation.